Antioxidant vitamin supplements and cardiovascular disease

Circulation. 2004 Aug 3;110(5):637-41. doi: 10.1161/01.CIR.0000137822.39831.F1.
No abstract available

Publication types

  • Review

MeSH terms

  • American Heart Association
  • Antioxidants / administration & dosage
  • Antioxidants / adverse effects
  • Antioxidants / therapeutic use*
  • Cardiotonic Agents / administration & dosage
  • Cardiotonic Agents / adverse effects
  • Cardiotonic Agents / therapeutic use*
  • Cardiovascular Diseases / drug therapy
  • Cardiovascular Diseases / epidemiology
  • Cardiovascular Diseases / prevention & control*
  • Controlled Clinical Trials as Topic
  • Diet
  • Dietary Supplements* / adverse effects
  • Disease Progression
  • Drug Interactions
  • Humans
  • Life Style
  • Meta-Analysis as Topic
  • Micronutrients / administration & dosage
  • Micronutrients / adverse effects
  • Micronutrients / therapeutic use
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / prevention & control
  • Nutritional Requirements
  • Practice Guidelines as Topic
  • Risk Reduction Behavior
  • Secondary Prevention
  • Vitamins / administration & dosage
  • Vitamins / adverse effects
  • Vitamins / therapeutic use*

Substances

  • Antioxidants
  • Cardiotonic Agents
  • Micronutrients
  • Vitamins
pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy